Wegovy® 0.25 mg is a once-weekly prescription injection containing semaglutide, a GLP-1 receptor agonist used for chronic weight management in adults who are overweight or living with obesity, alongside a reduced-calorie diet and increased physical activity. This 0.25 mg dose is typically the starting dose used during the initial phase of treatment to help the body gradually adjust to the medication.
Wegovy works by mimicking a natural hormone that targets areas of the brain involved in appetite regulation, helping to reduce hunger, increase feelings of fullness, and support healthier eating habits. It is not intended for immediate weight loss results but rather as part of a structured, long-term treatment plan guided by a healthcare professional.
Common side effects may include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation. Always use under medical supervision and follow your prescribed dosing schedule carefully.
Reviews
There are no reviews yet.